Novartis Future Growth
Future criteria checks 2/6
Novartis is forecast to grow earnings and revenue by 10% and 2.2% per annum respectively. EPS is expected to grow by 12.1% per annum. Return on equity is forecast to be 37.4% in 3 years.
Key information
10.0%
Earnings growth rate
12.1%
EPS growth rate
Pharmaceuticals earnings growth | 18.6% |
Revenue growth rate | 2.2% |
Future return on equity | 37.4% |
Analyst coverage | Good |
Last updated | 29 Apr 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 51,104 | 12,811 | 16,290 | 18,082 | 15 |
12/31/2025 | 50,616 | 11,895 | 15,444 | 17,008 | 18 |
12/31/2024 | 48,785 | 10,372 | 14,004 | 15,768 | 16 |
3/31/2024 | 47,733 | 9,107 | 12,071 | 13,766 | N/A |
12/31/2023 | 46,660 | 8,568 | 13,660 | 14,458 | N/A |
9/30/2023 | 54,217 | 8,151 | 14,459 | 15,374 | N/A |
6/30/2023 | 52,908 | 7,968 | 12,841 | 15,365 | N/A |
3/31/2023 | 41,694 | 5,976 | 14,009 | 15,544 | N/A |
12/31/2022 | 43,461 | 6,049 | 12,167 | 14,236 | N/A |
9/30/2022 | 46,017 | 21,042 | 11,545 | 14,009 | N/A |
6/30/2022 | 48,601 | 22,472 | 11,714 | 14,213 | N/A |
3/31/2022 | 52,997 | 24,184 | 12,349 | 14,590 | N/A |
12/31/2021 | 43,974 | 22,908 | 13,201 | 15,071 | N/A |
9/30/2021 | 52,385 | 9,807 | 13,015 | 15,192 | N/A |
6/30/2021 | 51,556 | 8,984 | 11,222 | 13,423 | N/A |
3/31/2021 | 49,884 | 7,955 | 10,699 | 13,252 | N/A |
12/31/2020 | 49,898 | 8,072 | 11,445 | 13,650 | N/A |
9/30/2020 | 49,584 | 7,103 | 11,743 | 13,185 | N/A |
6/30/2020 | 49,528 | 7,210 | 13,255 | 14,591 | N/A |
3/31/2020 | 49,930 | 7,451 | 13,077 | 14,240 | N/A |
12/31/2019 | 48,677 | 7,142 | 12,341 | 13,625 | N/A |
9/30/2019 | 47,858 | 7,238 | 12,122 | 13,851 | N/A |
6/30/2019 | 46,762 | 7,077 | 11,477 | 13,339 | N/A |
3/31/2019 | 46,391 | 12,697 | 11,778 | 13,671 | N/A |
12/31/2018 | 46,099 | 12,797 | 12,447 | 14,272 | N/A |
9/30/2018 | 47,366 | 13,552 | 11,748 | 13,914 | N/A |
6/30/2018 | 48,672 | 13,752 | 11,327 | 13,450 | N/A |
3/31/2018 | 49,513 | 8,004 | 10,855 | 13,090 | N/A |
12/31/2017 | 43,404 | 7,499 | N/A | 12,621 | N/A |
9/30/2017 | 49,527 | 6,684 | N/A | 12,804 | N/A |
6/30/2017 | 49,176 | 6,543 | N/A | 12,449 | N/A |
3/31/2017 | 49,361 | 6,367 | N/A | 11,978 | N/A |
12/31/2016 | 49,386 | 6,712 | N/A | 11,475 | N/A |
9/30/2016 | 49,606 | 6,807 | N/A | 12,041 | N/A |
6/30/2016 | 49,750 | 6,672 | N/A | 11,936 | N/A |
3/31/2016 | 49,967 | 6,722 | N/A | 11,735 | N/A |
12/31/2015 | 50,387 | 7,017 | N/A | 11,897 | N/A |
9/30/2015 | 50,635 | 8,417 | N/A | 12,945 | N/A |
6/30/2015 | 51,450 | 9,697 | N/A | 13,830 | N/A |
3/31/2015 | 52,503 | 10,536 | N/A | 14,260 | N/A |
12/31/2014 | 53,634 | 10,657 | N/A | 13,897 | N/A |
9/30/2014 | 53,908 | 10,191 | N/A | 13,142 | N/A |
6/30/2014 | 53,514 | 9,233 | N/A | 13,510 | N/A |
3/31/2014 | 52,845 | 9,095 | N/A | 12,687 | N/A |
12/31/2013 | 52,716 | 9,192 | N/A | 13,174 | N/A |
9/30/2013 | 54,100 | 9,191 | N/A | 13,351 | N/A |
6/30/2013 | 55,233 | 9,454 | N/A | 13,038 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: NVS's forecast earnings growth (10% per year) is above the savings rate (8.2%).
Earnings vs Market: NVS's earnings (10% per year) are forecast to grow slower than the AR market (40.5% per year).
High Growth Earnings: NVS's earnings are forecast to grow, but not significantly.
Revenue vs Market: NVS's revenue (2.2% per year) is forecast to grow slower than the AR market (5% per year).
High Growth Revenue: NVS's revenue (2.2% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: NVS's Return on Equity is forecast to be high in 3 years time (37.4%)